Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

356.24 -12.74 (-3.45%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
20 21 Next >
AMC Stock: The Horror Film Traders Keep Showing Up For
Just as AMC’s profitability was starting to improve, the dilution train has once again derailed traders' hopes of a turnaround. 
Via MarketBeat
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
 
Via Benzinga
16 Top Robotics Companies to Get to Know in 2023
What are the top robotics companies in the USA, as robotics continues to grow? Learn more about the best companies today with MarketBeat. 
Via MarketBeat
Topics Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Looking Into Stryker's Recent Short Interest
 
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today
 
Via Benzinga
$1000 Invested In Stryker 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Stryker Bull Expects Upside For Medtech Stock In '24, Ortho To Be 'Higher For Longer'
Shares of Stryker Corp (NYSE: SYK) continued to rise in early trading on Tuesday, after ending last week with gains. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
 
Via Benzinga
Is This MedTech Giant a Buy for Dividend Investors?
The company stands out as a titan of the medical devices industry. 
Via The Motley Fool
Where Stryker Stands With Analysts
 
Via Benzinga
Peering Into Stryker's Recent Short Interest
 
Via Benzinga
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand. 
Via MarketBeat
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
Via Talk Markets
Topics ETFs
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up 
Via MarketBeat
Topics Lawsuit
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
A Preview Of Stryker's Earnings
 
Via Benzinga
Looking At Stryker's Recent Unusual Options Activity
 
Via Benzinga
Stryker, NextEra Energy And A Stock Down 18% In Past Month: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Josh Brown of Ritholtz Wealth Management said he is sticking with NextEra Energy, Inc. (NYSE: NEE) 
Via Benzinga
Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
From Stryker Corporation
Via GlobeNewswire
Stryker, Wynn Resorts And A Chinese Tech Giant Expanding AI Capabilities: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named Alibaba Group Holding Limited (NYSE: BABA) as his 
Via Benzinga
Nikola's Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast's Cell Therapy For Kids: Today's Top Stories
Wall Street Journal 
Via Benzinga
$1000 Invested In Stryker 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
(SYK) - Analyzing Stryker's Short Interest
 
Via Benzinga
Where Stryker Stands With Analysts
 
Via Benzinga
Stryker Stock Gets A Boost From Annual Guidance Hike On Better Than Expected Q2 Earnings: The Details
Stryker Corporation (NYSE: SYK) reported Q2 sales of $5 billion, up 11.2% Y/Y (+11.9% in constant currency), beating the consen 
Via Benzinga
Stryker reports second quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
3 Stocks That Could Help You Retire a Millionaire
These three stocks have proven track records and possess catalysts that can enable them to continue growing. 
Via The Motley Fool
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.